相关实验视频
Updated: Aug 1, 2026

05:37
Intravitreous Injection for Establishing Ocular Diseases Model
Published on: October 1, 2007
36.8K
静脉内注射:通过减少临床废物来提高可持续性
Johannes Birtel1,2,3,4, Maximilian Hammer5, Nicolas Feltgen6
1Oxford Eye Hospital, Oxford University, Oxford, United Kingdom.
概括
减少内注射产生的废物对于可持续性至关重要. 最简单的方法可显著减少99%的临床废物和碳足迹,而不会影响患者的安全.
科学领域:
- 眼科医生 眼科 眼科
- 环境科学 环境科学
- 医疗保健废物管理 医疗保健废物管理
背景情况:
- 静脉内注射是一种常见的眼科手术,在德国每年进行超过一百万次.
- 这项研究涉及一次性注射器产生的大量废物和碳足迹.
研究的目的:
- 量化标准一次性内注射器套件的废弃物和碳足迹.
- 开发和评估这些程序的废物减少战略.
主要方法:
- 评估了来自8个第三级推中心的一次性注射器组的临床废物和碳足迹 (德国6个,英国2个).
- 评估了一种极简,节约材料的内注射方法的安全性和有效性.
主要成果:
- 每个注射器组平均有165g的废物,主要是塑料 (88%).
- 制造和焚烧100万注射器套件产生大量的二氧化碳排放 (分别为752.6t和301.7t).
- 节约材料的方法减少了99%的废物,而不会影响患者的安全.
结论:
- 实施一个资源节约的策略,用于内注射可以显著降低临床浪费.
- 这种方法有效地减少了与眼科手术相关的碳足迹,促进了环境可持续性.
相关概念视频
Routes of Drug Administration: Parenteral
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

